FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.

by Sandra Gordon

Exercise associated with increased survival after colon cancer, and screening costs remain a hurdle for women with dense breasts.

by Eric Fitzsimmons

After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.

by Miriam Díaz-Gilbert

Men with metastatic prostate cancer urged to ask questions about care, and early-phase study suggests benefit of pancreatic cancer vaccine.

by Marci A. Landsmann

Reports on breast density inform women of their status but raise questions about what to do next.

by Robin Roenker

Pesticide firms try to block cancer-related lawsuits, and cancer pain leads to greater tobacco and cannabis use.

by Kevin McLaughlin

Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.

by Laura Gesualdi-Gilmore

Researchers explore musical toxicity from cancer treatment, and kidney cancer vaccine shows potential in early trial.

by Eric Fitzsimmons

Challenges in developing and studying treatments call for new ways of thinking about cancer research.

by Eric Fitzsimmons

FDA approves an antibody-drug conjugate for people with HER2-ultralow breast cancer, and historic redlining practices have a lingering impact on cancer outcomes.

by Thomas Celona